Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | SR-8541A |
Trade Name | |
Synonyms | |
Drug Descriptions |
SR-8541A inhibits ENPP1, leading to the activation of the STING pathway and potentially resulting in enhanced immune response and tumor growth inhibition (Cancer Res (2023) 83 (8_Supplement): LB323). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Balstilimab + Botensilimab + SR-8541A | Balstilimab Botensilimab SR-8541A | 0 | 1 |
SR-8541A | SR-8541A | 0 | 1 |